Dr. Kathryn Diana Convers, MD

Dr. Convers practices at AdventHealth Home Infusion West Florida in Thonotosassa, Florida.

Dr. Convers' NPI, 1043417769, was assigned on June 27, 2007. Dr. Convers graduated from University of Medicine Sci In Poznan, Faculty Ii in 2005. Dr. Convers holds Florida license ME124960.

Dr. Convers' primary practice is AdventHealth Home Infusion West Florida, at 11461 N Us-301, Thonotosassa, FL 33592 in Hillsborough County. The practice phone is (407) 660-1122.

Dr. Convers' primary practice is AdventHealth Home Infusion West Florida in Thonotosassa, Florida. The medical group on file is Lakeland Regional Health. Dmand AI also links Dr. Convers to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Convers practices, 2 sites in all. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Convers' primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dr. Convers is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dmand AI has Dr. Convers' licenses on file in 3 states: Florida, Virginia and Missouri.

Dmand AI lists asthma, chronic nasal allergies, hives and immune deficiency disease among the conditions Dr. Convers treats.

CMS data shows 1,025 Medicare services from Dr. Convers across 5 procedure codes in 2024, for 93 Medicare patients. Medicare paid $17,389 for them. Every service was in an office.

CMS counts 93 Medicare patients who saw Dr. Convers in 2024. The largest group is 65 to 74, with 56 patients. 75% of them have high cholesterol, and 74% have high blood pressure. Their average risk score is 1.42, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Convers' median patient age at 45, with 65% women.

In 2024, Dr. Convers wrote 710 Medicare Part D claims for 121 patients. 48% of them were for generic drugs. CMS names the drug for 578 of them, across 25 drugs with 11 or more claims each, at $6,120,931 in total drug cost. In 2023, CMS named 421 claims across 21 drugs.

Dr. Convers accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 8 papers to Dr. Convers, published from 2012 to 2022. 2014 was the busiest year, with 3. The most frequent topics are Hypersensitivity and Radiography. Dr. Convers has published most often in Ann Allergy Asthma Immunol. Dr. Convers' most frequent co-authors are Raymond G. Slavin, MD, Christopher C. Chang, MD and Karla Lowe Davis, MD.

CMS Open Payments shows 552 general payments to Dr. Convers from 39 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $1,225.

Dr. Convers graduated from University of Medicine Sci In Poznan, Faculty Ii in 2005. Dr. Convers is a member of AAAAI and ACAAI.

Dr. Convers is in network with 19 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.